marijuana stocks

Form 8-K for ENERTOPIA CORP.

18-Nov-2014

Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial State

Item 3.02 Unregistered Sales of Equity SecuritiesThe Company issued 100,000 stock options. On July 15, 2014, the Company had adopted the 2014 Stock Option Plan. Based on this original Stock Option Plan, on November 18, 2014, the Company has granted 100,000 stock options to a Consultant of the Company. The exercise price of the stock options is $0.10, vested immediately, expiring November 18, 2019.

Name and Position Amount of stock options grant Maureen McGrath 100,000

 

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the options is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No.                        Description

   10.1       Form of Stock Option Agreement dated November 18, 2014
   99.1       News Release dated November 18, 2014


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 18, 2014

Enertopia Corp.
By: ____”Robert McAllister”______
Robert G. McAllister
President and Director

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Village Farms International, Inc. (VFF) Selected to Testify at Marijuana Rescheduling Hearing

Village Farms International Selected to Testify at Marijuana Rescheduling Hearing Village Farms…

with BMO Aurora Cannabis Inc. (ACBFF) Announces $200 Million Debt Facility with BMO

Aurora Cannabis Announces $200 Million Debt Facility with BMO Aurora Cannabis Inc.…

$CARA Initiates Adaptive Phase 2/3 Trial of I.V. CR845

Cara Therapeutics Initiates Adaptive Phase 2/3 Trial of I.V. CR845 for Treatment…

$ADVT Announces Exciting New Projects

Advantis Announces Exciting New Projects Will Be Rolled Out Within the Upcoming…